Floatz logo

Recombinant Human Plasminogen Activator

Neurological Improving

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityPhase 4 / ApprovedDormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Neurological Improving cohort.

Asset / SponsorPhaseRating
Ginkgolide
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4BB

Same molecule, other indications

Recombinant Human Plasminogen Activator is also rated in:

stroke disorderDormant
BB
Indicative ·
70 / 100
View asset →
ischemic strokeDormant
BB
Indicative ·
70 / 100
View asset →
brain infarctionDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →